IDEXX Laboratories, Inc. Stock price
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
539.9 USD | +0.07% | +1.47% | -2.72% |
Mar. 11 | Idexx Laboratories: Superior growth prospects | |
Mar. 07 | Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 3.99B | Sales 2025 * | 4.4B | Capitalization | 44.86B |
---|---|---|---|---|---|
Net income 2024 * | 928M | Net income 2025 * | 1.05B | EV / Sales 2024 * | 11.4 x |
Net Debt 2024 * | 490M | Net Debt 2025 * | 292M | EV / Sales 2025 * | 10.3 x |
P/E ratio 2024 * |
48.6
x | P/E ratio 2025 * |
42.7
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.42% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | +0.07% | ||
1 week | +1.47% | ||
Current month | -6.14% | ||
1 month | -5.55% | ||
3 months | -3.07% | ||
6 months | +23.56% | ||
Current year | -2.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 62 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 18 M€ | +6.77% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 539.9 | +0.07% | 290,111 |
24-03-27 | 539.6 | +1.69% | 308,904 |
24-03-26 | 530.6 | +0.17% | 398,139 |
24-03-25 | 529.7 | -0.19% | 363,892 |
24-03-22 | 530.7 | -0.26% | 251,360 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes